This review aims to define the effectiveness of the ketogenic diet (KD) for the management of sarcopenic obesity. As the combination of sarcopenia and obesity appears to have multiple negative metabolic effects, this narrative review discusses the effects of the ketogenic diet as a possible synergic intervention to decrease visceral adipose tissue (VAT) and fatty infiltration of the liver as well as modulate and improve the gut microbiota, inflammation and body composition. The results of this review support the evidence that the KD improves metabolic health and expands adipose tissue γδ T cells that are important for glycaemia control during obesity. The KD is also a therapeutic option for individuals with sarcopenic obesity due to its positive effect on VAT, adipose tissue, cytokines such as blood biochemistry, gut microbiota, and body composition. However, the long-term effect of a KD on these outcomes requires further investigations before general recommendations can be made.

The Ketogenic Diet: Is It an Answer for Sarcopenic Obesity? / Z. Ilyas, S. Perna, T.A. Alalwan, M. Nauman Zahid, D. Spadaccini, C. Gasparri, G. Peroni, A. Faragli, A. Alogna, E. La Porta, A. Ali Redha, M. Negro, G. Cerullo, G. D'Antona, M. Rondanelli. - In: NUTRIENTS. - ISSN 2072-6643. - 14:3(2022), pp. 620.1-620.10. [10.3390/nu14030620]

The Ketogenic Diet: Is It an Answer for Sarcopenic Obesity?

S. Perna
Secondo
;
2022

Abstract

This review aims to define the effectiveness of the ketogenic diet (KD) for the management of sarcopenic obesity. As the combination of sarcopenia and obesity appears to have multiple negative metabolic effects, this narrative review discusses the effects of the ketogenic diet as a possible synergic intervention to decrease visceral adipose tissue (VAT) and fatty infiltration of the liver as well as modulate and improve the gut microbiota, inflammation and body composition. The results of this review support the evidence that the KD improves metabolic health and expands adipose tissue γδ T cells that are important for glycaemia control during obesity. The KD is also a therapeutic option for individuals with sarcopenic obesity due to its positive effect on VAT, adipose tissue, cytokines such as blood biochemistry, gut microbiota, and body composition. However, the long-term effect of a KD on these outcomes requires further investigations before general recommendations can be made.
cytokine; fatty liver; gut microbiota; ketogenic diet; physical inactivity; sarcopenia; visceral adipose tissue (VAT)
Settore MED/49 - Scienze Tecniche Dietetiche Applicate
2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
nutrients-14-00620.pdf

accesso aperto

Descrizione: Review
Tipologia: Publisher's version/PDF
Dimensione 278.2 kB
Formato Adobe PDF
278.2 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/955956
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 10
social impact